Symposium 8: Real-world data in Japan, overview and examples: JSPE Medical and healthcare database utilization committee
Tracks
Track 4
Sunday, October 13, 2024 |
14:45 - 16:15 |
Faculty of Medicine Building 1 |
Details
Real-world data (RWDs) play an important role in the pharmacoepidemiological studies. Especially, it is vital to select a database based on data suitability for purpose. In recent years, various medical information databases such as electronic medical records, claims data, medical registries, and personal health records (PHRs) have become available in Japan. Therefore, researchers need to understand their suitability for the epidemiological design they are going to study based on the generation process and characteristics of each database. To build evidence properly, it is useful to learn about points to consider from actual research cases.
RWDs have own characteristics depends on healthcare systems. In recent years, some pharmacoepidemiological studies using multinational data have been reported. Therefore, we believe that it is useful to share the Japanese healthcare environment, available medical information databases, their generation process, characteristics, and research cases with researchers in other countries, including those in the Asian region.
Speaker
Prof. Shinobu Imai
Showa university
Presenter
Biography
Academic backgrounds
Graduation Date 31-Mar-2011
The Doctor’s Program of the Graduate School of Medical and Dental Sciences of Tokyo Medical and Dental
University, Japan; Health Care Informatics
Graduation Date 17-Mar-2006
The master’s Program of the Graduate School of Tokyo Medical and Dental University, Japan; Medical
Administration
Graduation Date 21-Mar-1997
The Faculty of Pharmacy School of Pharmacy, Kitasato University, Japan; Pharmaceutical Sciences
-----------------------------------------------------------------------------------------------------------------------------------------------------
Work Experiences
01-Aug-2022 to present
Professor
Division of Pharmacoepidemiology, Department of Healthcare and Regulatory Sciences, Showa University,
School of Pharmacy, Tokyo, Japan
01-Apr-2019
Associate professor
Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and
Life Sciences, Tokyo, Japan
01-Apr-2014
Assistant researcher
National Hospital Organization Headquarters
01-Apr-2013
Visiting researcher
Section of Social Medicine, Department of Community Medicine and Public Health, Sahlgrenska Academy,
University of Gothenburg, Sweden
01-May-2010
Analyst / Assistant Professor
University of Tokyo Hospital, The Database Center of the National University Hospitals Japan
01-Sep-2005
Director of Human Resources / General Manager
Kanamachi Central Hospital, Tokyo, Japan
01-04-1997
Pharmacist
University of Tokyo Hospital, Tokyo, Japan
Dr. Ryo WATANABE
Kanagawa University of Human Services
Presenter
Biography
Dr. Ryo WATANABE is a professor at the Graduate School of Health Innovation and the deputy director of the Center for Innovation Policy at Kanagawa University of Human Services in Kanagawa, Japan. His academic disciplines include health policy, health administration, and managerial accounting in healthcare. As a researcher, he focuses on health policy using secondary data including claim data an health check-up data. He received a B.S.H. from Ohio University and an M.P.H.
from the University of Tokyo School of Public Health. He earned his Ph.D. from Hitotsubashi University in 2015. In 2018, he was appointed as a founding faculty member of the Graduate School of Health Innovation at Kanagawa University of Human Services. In addition to his academic roles, Dr. Watanabe serves as the president of the Initiative for Social & Public Health (iSPH; a non-profit organization) and as a scientific researcher at the Japan Agency for Medical Research and Development.
Dr. Miho Ishimaru
Tokyo Medical and Dental University
Presenter
Biography
Dr. Miho Ishimaru is a project assistant professor at the Institute of Education,
Tokyo Medical and Dental University, Tokyo, Japan. She is a dentist and earned a Bachelor of Dental Surgery from Hokkaido University in 2012, a Master of Public Health from The University of Tokyo in 2016, and a Ph.D. in Medicine from The University of Tokyo in 2020. Her areas of expertise include clinical research and health services research in the field of dentistry utilizing real-world data.
Dr Maki Komamine
Epidemiologist
Pharmaceuticals and Medical Devices Agency
Presenter
Biography
She is a member of the Division of Pharmacoepidemiology, Office of Pharmacovigilance I at Pharmaceuticals and Medical Devices Agency (PMDA). In this position, she is engaged in pharmacoepidemiology studies for drug safety by using Real-World Data. She started working in PMDA after graduating from the pharmaceutical college and trained in epidemiology at Kyoto University School of Public Health during her tenure.
Moderator
Akiihro Nakajima
Teijin Pharma Limited.
Kanae Togo
Pfizer Japan Inc.
